Mary Hahn

676 total citations
7 papers, 531 citations indexed

About

Mary Hahn is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mary Hahn has authored 7 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Mary Hahn's work include Glioma Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Signaling Pathways in Disease (1 paper). Mary Hahn is often cited by papers focused on Glioma Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Signaling Pathways in Disease (1 paper). Mary Hahn collaborates with scholars based in United States, Australia and South Korea. Mary Hahn's co-authors include Raúl Catena, Dingcheng Gao, Vivek Mittal, Hyejin Choi, Seongho Ryu, Linda T. Vahdat, Natasha Joshi, Bradley S. Evans, Luena Papa and Doris Germain and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Cell and Cancer Research.

In The Last Decade

Mary Hahn

7 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Hahn United States 5 294 202 197 107 55 7 531
Rolando Pérez‐Lorenzo United States 15 460 1.6× 196 1.0× 165 0.8× 135 1.3× 52 0.9× 24 667
Ying-Yi Li China 13 344 1.2× 263 1.3× 173 0.9× 68 0.6× 56 1.0× 30 624
Raquel Batlle Spain 7 345 1.2× 227 1.1× 190 1.0× 87 0.8× 44 0.8× 7 552
Helen Sadik United States 11 410 1.4× 265 1.3× 290 1.5× 109 1.0× 44 0.8× 11 705
Huizhi Sun China 16 478 1.6× 188 0.9× 313 1.6× 76 0.7× 52 0.9× 23 641
Valery Adorno-Cruz United States 6 324 1.1× 208 1.0× 205 1.0× 45 0.4× 39 0.7× 6 513
Byung–Kyu Ryu South Korea 10 374 1.3× 135 0.7× 120 0.6× 63 0.6× 59 1.1× 11 562
Rémi Samain France 9 311 1.1× 347 1.7× 141 0.7× 153 1.4× 99 1.8× 12 641
Xinyun Xu China 11 266 0.9× 183 0.9× 182 0.9× 199 1.9× 22 0.4× 24 572

Countries citing papers authored by Mary Hahn

Since Specialization
Citations

This map shows the geographic impact of Mary Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Hahn more than expected).

Fields of papers citing papers by Mary Hahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Hahn. The network helps show where Mary Hahn may publish in the future.

Co-authorship network of co-authors of Mary Hahn

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Hahn. A scholar is included among the top collaborators of Mary Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Hahn. Mary Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Chiu, Daniel, Jingjing Qi, Tin Htwe Thin, et al.. (2023). A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma. Cancer Research Communications. 3(1). 130–139. 19 indexed citations
2.
Hormigo, Adı́lia, Daniel Chiu, Mary Hahn, et al.. (2021). CTIM-09. PHASE I STUDY OF PD-L1 INHIBITION WITH AVELUMAB AND LASER INTERSTITIAL THERMAL THERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA. Neuro-Oncology. 23(Supplement_6). vi51–vi51. 3 indexed citations
3.
Papa, Luena, Mary Hahn, Ellen L. Marsh, Bradley S. Evans, & Doris Germain. (2014). SOD2 to SOD1 Switch in Breast Cancer. Journal of Biological Chemistry. 289(9). 5412–5416. 107 indexed citations
4.
Ryu, Seongho, Kevin McDonnell, Hyejin Choi, et al.. (2013). Suppression of miRNA-708 by Polycomb Group Promotes Metastases by Calcium-Induced Cell Migration. Cancer Cell. 23(1). 63–76. 126 indexed citations
5.
Gao, Dingcheng, Natasha Joshi, Hyejin Choi, et al.. (2012). Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition. Cancer Research. 72(6). 1384–1394. 234 indexed citations
6.
Mellick, Albert S., Daniel J. Nolan, Dingcheng Gao, et al.. (2010). Using the Transcription Factor Inhibitor of DNA Binding 1 to Selectively Target Endothelial Progenitor Cells Offers Novel Strategies to Inhibit Tumor Angiogenesis and Growth. Cancer Research. 70(18). 7273–7282. 41 indexed citations
7.
Hahn, Mary, et al.. (2004). Development of a tetracycline-inducible system for expression of the Ca2+ permeable TRPL channel and the killing of prostate cancer cells. 2. 389–402. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026